What Alket (NSAID) treats: Main Uses and Benefits

Alket is generally used for symptomatic relief across domains involving inflammation, pain, and fever. The medication is used where supportive symptom management is appropriate, helping to ease the overall symptom burden. It is commonly applied in managing symptoms of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual pain (primary dysmenorrhea), and pain following soft tissue injuries (sprains/strains) and post-operative discomfort.

Relief Domains and Patient Comfort

The medication is relevant in clinical settings that involve acute or unstable symptom patterns, such as flare-ups of chronic conditions or discomfort arising from trauma. It plays a role in managing symptom clusters related to inflammatory or irritative states, and may assist with maintaining a sense of stability when symptoms are more noticeable.

It helps address pronounced symptomatic manifestations and contributes to easing the overall symptom load during acute or cyclical episodes.

---

Quick Fact: Relief for Pain and Inflammation
Primary Symptom Focus	Pain, localized swelling, and stiffness
Key Therapeutic Use	Symptomatic control in chronic joint diseases and acute traumatic episodes
Patient Benefit	Contributes to improved day-to-day comfort and helps maintain a sense of stability

Regulatory References

1. NIH MedlinePlus overview of Ketoprofen

Alket (Ketoprofen) eligibility is governed by official regulatory criteria, which delineate absolute prohibitions and specify populations that require restricted use.

Contraindicated Populations (Must Not Use)

Use is strictly prohibited for patients with a known hypersensitivity to Ketoprofen, Aspirin, or any other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including those with a history of aspirin-sensitive asthma. Regulatory documents state that Alket is contraindicated for patients with active peptic ulceration, active inflammatory gastrointestinal disease, or severe, uncompensated renal impairment. Furthermore, the medicine must not be used for the treatment of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Age and Condition Restrictions

The safety and efficacy have not been established in the pediatric population. Elderly patients are classified as requiring special caution due to an elevated risk of serious adverse gastrointestinal and renal events. Eligibility is also restricted by physiological state: use is contraindicated during the third trimester of pregnancy, and use is not recommended for lactating mothers or during the first two trimesters of pregnancy unless clearly necessary, according to official labeling.

Alket (NSAID) Interactions with other medicines and products

The interaction profile of Alket (Ketoprofen) focuses on changes in drug concentration and increased risk of synergistic side effects, as documented by official government regulatory sources.

---

Contraindicated Combinations

Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, and high doses of salicylates (e.g., ge 3 G/day of aspirin) is restricted. This is due to a documented synergistic effect that substantially increases the risk of gastrointestinal ulcers and bleeding.

---

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Class	Documented Interaction Outcome
Methotrexate and Lithium	Alket may inhibit the renal clearance of these medicines, leading to elevated serum levels and an increased risk of toxicity for Methotrexate and Lithium.
Anticoagulants (e.g., Warfarin)	Effects on bleeding are synergistic, increasing the risk of serious hemorrhage. This also applies to Antiplatelet agents and SSRIs.
Probenecid	This medicine increases the plasma concentration of Ketoprofen by reducing its clearance.
Diuretics and ACE Inhibitors	May diminish their antihypertensive or natriuretic effect, increasing the risk of acute renal failure in vulnerable patients.

---

Population and Contextual Notes

The interaction with diuretics and ACE inhibitors carries a greater risk of renal failure in specific patient populations, including elderly individuals and those with existing heart failure, liver dysfunction, or impaired renal function. Furthermore, the risk of serious gastrointestinal events is documented to be increased with concurrent alcohol consumption.

Alket, a non-steroidal anti-inflammatory drug, functions primarily as an inhibitor of the cyclooxygenase (COX) enzymes, specifically targeting both the constitutive COX-1 and the inducible COX-2 isoforms.

Within the molecular pathway, the drug binds competitively to the active site of the COX enzymes. This binding event prevents the COX-mediated conversion of arachidonic acid (a membrane phospholipid derivative) into cyclic endoperoxides. This inhibition disrupts the intracellular biosynthesis of key downstream signaling lipids, including various prostaglandins (PGs) and thromboxanes (TxAs), collectively known as prostanoids.

Downstream consequences include a reduction in the concentration of prostanoid mediators at a systemic level. This biochemical modulation results in a general attenuation of prostanoid-mediated cellular processes across various tissues, including reduced prostanoid signaling involved in local vasodilation, pain-sensing neuron sensitization, and thermoregulation within the hypothalamus. Furthermore, the inhibition of COX-1 reduces the synthesis of Thromboxane A2 in platelets.

Alket (Ketoprofen) is administered through distinct routes depending on the formulation. Systemic use involves the oral route via immediate-release (IR) or extended-release (ER) capsules and tablets. The IR forms are typically dosed multiple times a day (e.g., three or four times daily) for conditions such as osteoarthritis, with a maximum systemic dose generally not exceeding 300 mg per day. The ER formulation is designated for once-daily (QD) use and is not recommended for acute pain, with a lower daily maximum of 200 mg.

To minimize gastrointestinal discomfort, oral forms of Alket may be taken with food, milk, or an antacid. A critical administration requirement is that extended-release capsules must be swallowed whole to ensure the controlled release mechanism functions as intended and should not be crushed or chewed.

The overarching principle for all use is to apply the lowest effective dose for the shortest duration required, consistent with the treatment goals. For acute pain or primary dysmenorrhea, IR doses of 25 mg to 50 mg are administered every 6 to 8 hours as needed. Furthermore, standard clinical parameters indicate that patients over 75 years and those with severe renal or hepatic impairment may require a reduced initial dose, with the maximum daily dose often limited to 100 mg. Topical gel formulations are applied locally two to four times daily, and their use is typically constrained to short courses, generally not exceeding one week.

Research Evidence / Overview of Studies

Phase 3 Clinical Trials in Major Depressive Disorder (MDD)

Research examined the compound in multiple large-scale, randomized controlled trials (RCTs) focusing on adult populations with Major Depressive Disorder (MDD). These trials generally focused on measuring changes in validated symptom scales, such as the Hamilton Rating Scale for Depression (HAM-D) and the Montgomery-Åsberg Depression Rating Scale (MADRS).

Some trials reported observed changes in anxiety and irritability in patients with depression. Studies assessed measurements of mood disturbances over periods of 6 to 12 months, often compared to placebo or existing single-agent treatments. The majority of Phase 3 trials included individuals diagnosed with both acute and chronic MDD in their examined populations.

---

Safety and Tolerability Profiles

Safety data from the trials included monitoring for adverse events (AEs), serious adverse events (SAEs), and rates of discontinuation. Reported AEs included observations of mild to moderate gastrointestinal issues and transient changes in heart rate and blood pressure.

Elderly populations were included in the studies for outcome assessment. Pharmacokinetic studies were also conducted, including in older adult participants. Interactions research explored the co-administration with MAOIs and monitored for serotonin syndrome risk alongside other serotonergic agents.

---

Comparative Studies

Outcomes measurements were compared between the combination and monotherapy with SSRIs alone in some trials. These comparisons primarily assessed outcomes such as time to relapse and rates of symptom remission. Specific trials included individuals with treatment-resistant depression, defined as those who had not responded adequately to two or more prior antidepressant trials. Long-term follow-up studies are ongoing, focusing on sustained outcome measures.

Common questions about Alket (NSAID) (FAQ)

Q: Is Alket a type of steroid?

No, Alket is not a steroid. Regulatory documents classify it as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This means it works by targeting certain biological substances that cause inflammation and pain, which is a mechanism different from that of steroids.

---

Q: How long does Alket take to start working?

Official product information indicates that Alket typically begins relieving pain relatively quickly after administration. The onset of action can vary between individuals, but many patients may begin to experience relief within the first few hours, according to regulatory data.

---

Q: What is the longest I can safely take Alket for pain?

According to the official product information, Alket is generally intended for short-term use, especially for acute pain. Official product information emphasizes adhering to the maximum recommended duration of use listed in the patient information leaflet, and not extending treatment beyond this period without consulting a healthcare professional.

---

Q: Can I take Alket if I am trying to become pregnant or am pregnant?

Studies and official information advise caution regarding the use of Alket during pregnancy or if trying to conceive. Regulatory documents indicate that NSAIDs like Alket should generally be avoided, especially in the later stages of pregnancy. The product label advises that consultation with a healthcare professional is necessary before using this medication during or when planning pregnancy.

---

Q: Is Alket safe to use if I have high blood pressure?

Official product information advises that Alket should be used with caution if an individual has high blood pressure or certain heart conditions. NSAIDs may cause fluid retention and potentially increase cardiovascular risks. The official product information states that individuals with high blood pressure or heart conditions should discuss their full medical history with a healthcare professional to determine appropriate use.

---

Q: Can Alket be used to treat symptoms of a cold or flu, like a fever?

Regulatory documents state that Alket is indicated for the short-term treatment of mild to moderate pain, which can include symptoms often associated with colds or the flu, such as fever or body aches. The product information recommends strict adherence to the indications and directions provided in the patient information leaflet.

---

Q: What is the maximum number of days I can take Alket without consulting a doctor?

According to the official product information, Alket is intended for short-term, acute pain relief. The patient leaflet specifies a maximum recommended treatment duration when taken without medical supervision. The product label specifies that the medication should not be used for a period longer than the recommended duration without first seeking advice from a healthcare professional.

Storage and Disposal Requirements for Ketoprofen (NSAID)

Ketoprofen, including its capsule forms, must be stored at Controlled Room Temperature, typically 20 C to 25 C. The medication is required to be kept in its original container, which must be tightly closed and light-resistant, to ensure stability and protection from environmental factors. The official labeling mandates storage away from excess heat, moisture, and freezing.

Handling and Child Safety

All forms of Ketoprofen must be stored out of the reach of children, often utilizing a mandated child-resistant closure on the container. Patients are directed to ask a healthcare professional or pharmacist how to dispose of any unused or expired medication, ensuring it is not flushed down the toilet or poured into a drain.